Graham-Little-Piccardi-Lasseur Syndrome: A Case Report
INTRODUCTION
Graham-Little-Piccardi-Lasseur Syndrome (GLPLS) is a rare clinical subtype of lichen planopilaris (LPP) that manifests as a triad of scarring alopecia of the scalp, nonscarring alopecia of the axillary and the pubic skin, and widespread lichenoid follicular papules.1 GLPLS more commonly affects women (male-to-female ratio ≃ 1:4), with the classic patient being a middle-aged Ca …
INTRODUCTION
Graham-Little-Piccardi-Lasseur Syndrome (GLPLS) is a rare clinical subtype of lichen planopilaris (LPP) that manifests as a triad of scarring alopecia of the scalp, nonscarring alopecia of the axillary and the pubic skin, and widespread lichenoid follicular papules.1 GLPLS more commonly affects women (male-to-female ratio ≃ 1:4), with the classic patient being a middle-aged Ca … Continue reading "Graham-Little-Piccardi-Lasseur Syndrome: A Case Report"
A 55 year-old woman comes in for a rash in her mouth pictured below. Also on exam, you note a scarring alopecia of the scalp. From the below options, which other location should you examine for hair loss?
A. Eyebrows
B. Legs
C. Axilla
D. Arms
E. Eyelashes
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
On this Mnemonic Monday, we challenge you to remember the geographical areas and associated species known for NEW WORLD leishmaniasis transmission with the following mnemonic:
Let's Go Get Brazilian Blowouts in Mexico
Let's = “lutz” aka Lutzomya sandfly species responsible for transmitting new world leishmaniasis
Brazilian = L. braziliensis complex, leishmaniasis species commonly … 
Hair loss can be such a challenging disease to treat, especially with the social toll it can take on patients. Do you struggle to keep up with the newest treatments and data on hair loss? If so, keep reading as we learn from Dr. Shilpi Khetarpal, Associate Professor of Dermatology and Director of Cosmetic Dermatology and Lasers at Cleveland Clinic, about adjunctive therapies for hair loss based on … 
Androgenic alopecia (AGA) is one of the most common forms of hair loss and represents a frequently faced disabling concern in dermatology visits. Targeting the 5α-dihydrotestosterone (DHT) pathway has been shown to be an efficacious mechanism of action, with finasteride being the only systemic FDA-approved drug to treat male AGA. Recently, its sister drug, dutasteride, has been increasingly utili … 